Juvenile exposure to methylphenidate reduces cocaine reward and alters netrin-1 receptor expression in adulthood

Behavioural Brain Research

Volumn 229, Issue 1, 2012, Pages 202-207

  Argento, Jessica K ^a   Arvanitogiannis, Andreas ^b   Flores, Cecilia ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b and Applied Physiology   (Canada)

Author keywords

Conditioned place preference; DCC; Development; Guidance cues; Stimulant drugs; Ventral tegmental area

Indexed keywords

COCAINE; METHYLPHENIDATE; NETRIN 1; NETRIN 1 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; IMMUNOBLOTTING; INSTRUMENTAL CONDITIONING; INTERMETHOD COMPARISON; JUVENILE ANIMAL; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REWARD; SENSITIVITY ANALYSIS; VENTRAL TEGMENTUM; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; COCAINE; CONDITIONING, OPERANT; CUES; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHYLPHENIDATE; MICE; MICE, INBRED C57BL; RECEPTORS, CELL SURFACE; REWARD; TUMOR SUPPRESSOR PROTEINS; VENTRAL TEGMENTAL AREA;

EID: 84856138855     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.01.008     Document Type: Article

References (53)

1. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988, 85:5274-5278.
2. Volkow N.D., Wang G.J., Fowler J.S., Fischman M., Foltin R., Abumrad N.N., et al. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci 1999, 65:PL7-PL12.
3. Leonard B.E., McCartan D., White J., King D.J. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 2004, 19:151-180.
4. Volkow N.D., Wang G., Fowler J.S., Logan J., Gerasimov M., Maynard L., et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001, 21:RC121.
5. Dafny N., Yang P.B. The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res Bull 2006, 68:393-405.
6. Andersen S.L., Arvanitogiannis A., Pliakas A.M., LeBlanc C., Carlezon W.A. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 2002, 5:13-14.
7. Carlezon W.A., Mague S.D., Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 2003, 54:1330-1337.
8. Adriani W., Leo D., Greco D., Rea M., di Porzio U., Laviola G., et al. Methylphenidate administration to adolescent rats determines plastic changes on reward-related behavior and striatal gene expression. Neuropsychopharmacology 2006, 31:1946-1956.
9. Brandon C.L., Marinelli M., Baker L.K., White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 2001, 25:651-661.
10. Achat-Mendes C., Anderson K.L., Itzhak Y. Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology 2003, 45:106-115.
11. Burton C.L., Nobrega J.N., Fletcher P.J. The effects of adolescent methylphenidate self-administration on responding for a conditioned reward, amphetamine-induced locomotor activity, and neuronal activation. Psychopharmacology (Berl) 2010, 208:455-468.
12. Yang P.B., Swann A.C., Dafny N. Psychostimulants given in adolescence modulate their effects in adulthood using the open field and the wheel-running assays. Brain Res Bull 2010, 82:208-217.
13. Crawford C.A., Baella S.A., Farley C.M., Herbert M.S., Horn L.R., Campbell R.H., et al. Early methylphenidate exposure enhances cocaine self-administration but not cocaine-induced conditioned place preference in young adult rats. Psychopharmacology (Berl) 2011, 213:43-52.
14. Manitt C., Kennedy T.E. Where the rubber meets the road: netrin expression and function in developing and adult nervous systems. Prog Brain Res 2002, 137:425-442.
15. Barallobre M.J., Pascual M., Del Rio J.A., Soriano E. The netrin family of guidance factors: emphasis on netrin-1 signalling. Brain Res Brain Res Rev 2005, 49:22-47.
16. Furrer M.P., Kim S., Wolf B., Chiba A. Robo and frazzled/DCC mediate dendritic guidance at the CNS midline. Nat Neurosci 2003, 6:223-230.
17. Suli A., Mortimer N., Shepherd I., Chien C.B. Netrin/DCC signaling controls contralateral dendrites of octavolateralis efferent neurons. J Neurosci 2006, 26:13328-13337.
18. Manitt C., Mimee A., Eng C., Pokinko M., Stroh T., Cooper H.M., et al. The Netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry. J Neurosci 2011, 31:8381-8394.
19. Osborne P.B., Halliday G.M., Cooper H.M., Keast J.R. Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents. Neuroscience 2005, 131:671-681.
20. Grant A., Hoops D., Labelle-Dumais C., Prevost M., Rajabi H., Kolb B., et al. Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine. Eur J Neurosci 2007, 26:3215-3228.
21. Yetnikoff L., Labelle-Dumais C., Flores C. Regulation of netrin-1 receptors by amphetamine in the adult brain. Neuroscience 2007, 150:764-773.
22. Manitt C., Labelle-Dumais C., Eng C., Grant A., Mimee A., Stroh T., et al. Peri-pubertal emergence of UNC-5 homologue expression by dopamine neurons in rodents. PLoS ONE 2010, 5:e11463.
23. Yetnikoff L., Eng C., Benning S., Flores C. Netrin-1 receptor in the ventral tegmental area is required for sensitization to amphetamine. Eur J Neurosci 2010, 31:1292-1302.
24. Kalivas P.W., Weber B. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 1988, 245:1095-1102.
25. Vezina P., Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res 1990, 516:99-106.
26. Vezina P. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res 1993, 605:332-337.
27. Vezina P. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci 1996, 16:2411-2420.
28. Cador M., Bjijou Y., Stinus L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 1995, 65:385-395.
29. Bjijou Y., Stinus L., Le Moal M., Cador M. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of d-amphetamine. J Pharmacol Exp Ther 1996, 277:1177-1187.
30. Vezina P., Lorrain D.S., Arnold G.M., Austin J.D., Suto N. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 2002, 22:4654-4662.
31. Suto N., Austin J.D., Tanabe L.M., Kramer M.K., Wright D.A., Vezina P. Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in a D1 dopamine receptor dependent manner. Neuropsychopharmacology 2002, 27:970-979.
32. Suto N., Tanabe L.M., Austin J.D., Creekmore E., Vezina P. Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in an NMDA, AMPA/kainate, and metabotropic glutamate receptor-dependent manner. Neuropsychopharmacology 2003, 28:629-639.
33. David V., Segu L., Buhot M.C., Ichaye M., Cazala P. Rewarding effects elicited by cocaine microinjections into the ventral tegmental area of C57BL/6 mice: involvement of dopamine D1 and serotonin1B receptors. Psychopharmacology (Berl) 2004, 174:367-375.
34. Flores C., Manitt C., Rodaros D., Thompson K.M., Rajabi H., Luk K.C., et al. Netrin receptor deficient mice exhibit functional reorganization of dopaminergic systems and do not sensitize to amphetamine. Mol Psychiatry 2005, 10:606-612.
35. Yetnikoff L., Almey A., Arvanitogiannis A., Flores C. Abolition of the behavioral phenotype of adult netrin-1 receptor deficient mice by exposure to amphetamine during the juvenile period. Psychopharmacology (Berl) 2011, 217:505-514.
36. Grant A., Speed Z., Labelle-Dumais C., Flores C. Post-pubertal emergence of a dopamine phenotype in netrin-1 receptor-deficient mice. Eur J Neurosci 2009, 30:1318-1328.
37. Augustyniak P.N., Kourrich S., Rezazadeh S.M., Stewart J., Arvanitogiannis A. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder. Behav Brain Res 2006, 167:379-382.
38. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., et al. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther 2000, 295:51-57.
39. Kuczenski R., Segal D.S. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry 2005, 57:1391-1396.
40. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, New York. 2nd ed.
41. Manitt C., Thompson K.M., Kennedy T.E. Developmental shift in expression of netrin receptors in the rat spinal cord: predominance of UNC-5 homologues in adulthood. J Neurosci Res 2004, 77:690-700.
42. Romero-Calvo I., Ocon B., Martinez-Moya P., Suarez M.D., Zarzuelo A., Martinez-Augustin O., et al. Reversible Ponceau staining as a loading control alternative to actin in western blots. Anal Biochem 2010, 401:318-320.
43. Boudreau A.C., Wolf M.E. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J Neurosci 2005, 25:9144-9151.
44. Kovacs K., Lajtha A., Sershen H. Effect of nicotine and cocaine on neurofilaments and receptors in whole brain tissue and synaptoneurosome preparations. Brain Res Bull 2010, 82:109-117.
45. Ghasemzadeh M.B., Vasudevan P., Giles C., Purgianto A., Seubert C., Mantsch J.R. Glutamatergic plasticity in medial prefrontal cortex and ventral tegmental area following extended-access cocaine self-administration. Brain Res 2011, 1413:60-71.
46. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979, 6:65-70.
47. Zhu N., Weedon J., Dow-Edwards D.L. Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats. Behav Neurosci 2007, 121:1272-1279.
48. Dommett E.J., Henderson E.L., Westwell M.S., Greenfield S.A. Methylphenidate amplifies long-term plasticity in the hippocampus via noradrenergic mechanisms. Learn Mem 2008, 15:580-586.
49. Flores C. Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine system. J Psychiatry Neurosci 2011, 36:100171.
50. Federici M., Geracitano R., Bernardi G., Mercuri N.B. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain. Biol Psychiatry 2005, 57:361-365.
51. Prieto-Gomez B., Benitez M.T., Vazquez-Alvarez A.M., Yang P.B., Reyes Vazquez C., Dafny N. Dopaminergic ventral tegmental neurons modulated by methylphenidate. Life Sci 2004, 74:1581-1592.
52. Brandon C.L., Marinelli M., White F.J. Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons. Biol Psychiatry 2003, 54:1338-1344.
53. Roberts D.C., Koob G.F. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav 1982, 17:901-904.